Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Anemia: full-pipeline trial registry
14 of 74 indexed Anemia trials are currently recruiting.
Corpus placement: #183 of 28,707 conditions by registered trial count.
74 US clinical trials · 14 currently recruiting · #183 of 28,707 conditions by registered trial count
Anemia: 74 US clinical trials tracked, 14 recruiting.
Anemia is the subject of 74 registered US clinical trials on ClinicalTrials.gov, 14 of them currently open to new participants. 26 are in Phase 3-4 (later-stage) and 25 in Phase 1-2 (earlier-stage). The most active sponsor is Akebia Therapeutics, running 5 of these trials.
Enrollment posture brief
Registry condition anemia
OPEN 14 | RECR 19% | LATE 26 | EARLY 25 | RANK #183 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Colonoscopy (19% recruiting · 21 trials)
Anemia lists 14 open slots (19% of 74 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Anemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Anemia is recruiting below its size-band peers.
14 of 74 indexed trials (18.9%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Anemia trials is spread across many organizations.
Akebia Therapeutics accounts for 5 of 74 trials (6.8%). 54 distinct sponsors appear on at least one study for this condition label.
-
Typical Anemia enrolment sits around 161 participants.
Median target enrolment is 161 among the 73 trials that report a genuine target (sentinel values excluded). 27 of those (37%) plan for fewer than 100 participants.
-
Anemia research is mostly interventional.
69 interventional and 5 observational studies make up this index (93.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
74 total, page 2 of 2
Measurement of Total Hemoglobin by Pulse Oximetry in Neonatal Population
Masimo Corporation
NCT03120702
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Eastern Cooperative Oncology Group
NCT00003138
IV Iron Safety: Evaluation of Iron Species in Healthy Subjects
University of Maryland, Baltimore
NCT02399449
Practical Anemia Bundle for SusTained Blood Recovery
Mayo Clinic
NCT05167734
Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
Bayer
NCT02064426
Umbilical Cord Blood Use For Admission Blood Tests of Very Low Birth Weight Preterm Neonates: A Multi-center Randomized Clinical Trial
Capt Alicia Prescott
NCT02103296
BVA-200 vs BVA-100 Validation Study
Daxor Corporation
NCT06227819
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
University of Alabama at Birmingham
NCT02888171
Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients
Watson Pharmaceuticals
NCT00223964
Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF)
Mathew S. Maurer
NCT00286182
Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia
Albert Einstein College of Medicine
NCT01772420
Evaluate the Change in Iron, Vitamin D, and C-Reactive Protein Level (CRP) in a 12 to 24 Week Period
Avera McKennan Hospital & University Health Center
NCT01328704
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
University of Maryland, Baltimore
NCT00003398
Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
Hoffmann-La Roche
NCT03552393
A Phase 1 Study of LY2787106 in Cancer and Anemia
Eli Lilly and Company
NCT01340976
Placental Transfusion in Term Infants: A Pilot Study
University of Rhode Island
NCT01924572
Noninvasive Hemoglobin Repeatability and Reproducibility in a Blood Donation Setting
Masimo Corporation
NCT04490863
Milking the Umbilical Cord at Term Cesarean Birth
University of Rhode Island
NCT01630993
Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC Study
University of Michigan
NCT00396123
Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients
American Regent
NCT00721188
Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia
Akebia Therapeutics
NCT01235936
Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center
NCT02530515
BioRBC Survival in Adults With Prior Antibody Response to BioRBCs
John A Widness
NCT02077751
Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome
Fallon Clinic
NCT00053001
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 19 |
| Phase 3 | 20 |
| Phase 4 | 6 |
Top Sponsors
Named interventions
Most-linked intervention names on Anemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Anemia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Anemia page
74 registered trials, 14 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 14 Anemia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Akebia Therapeutics sponsors the most Anemia trials on record, review their full trial history before evaluating a specific study. See Akebia Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Anemia condition card totals 74 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.